Keyphrases
Positron Emission Tomography
90%
Zirconium-89 (89Zr)
86%
Nanoparticles
84%
Nanomedicine
64%
Inflammation
48%
Macrophages
46%
Tumor
41%
Myeloid Cells
40%
Nanoimmunotherapy
39%
High-density Lipoprotein Cholesterol (HDL-C)
39%
PET-MRI
39%
Nanotherapeutics
35%
Nonhuman Primate
32%
Cardiovascular Disease
29%
Biodistribution
28%
Tautomers
28%
Solid State
28%
Immunoimaging
28%
Myocardial Infarction
27%
Trained Immunity
27%
Multi-parameter
27%
Atherosclerotic Plaque
26%
Fluorinated
25%
Ischemic Heart Disease
25%
PET Imaging
24%
Liposomal Nanoparticles
24%
Nanoemulsion
23%
Plaque
22%
Immune Cells
21%
Nanobody
21%
Indazole
21%
1H-indazole
21%
Multimodal Imaging
21%
Imaging Approach
20%
Atherosclerotic Mice
20%
Liposomes
20%
Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6)
19%
Nanotracer
17%
Multiparametric Imaging
17%
Inducible Nitric Oxide Synthase
17%
Förster Resonance Energy Transfer
17%
Biological Evaluation
17%
Synthetic Evaluation
17%
Efficacy Assessment
17%
Tumor Targeting
17%
Safety Assessment
17%
Imaging-guided
17%
Solid-state NMR
17%
Tautomerism
17%
Voltage-gated Sodium Channel
17%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Atherosclerosis
94%
Neoplasm
75%
Mouse
69%
Nanomedicine
63%
Zirconium 89
58%
Inflammation
49%
High Density Lipoprotein
36%
Disease
32%
Tracer
29%
Biodistribution
27%
Indazole Derivative
25%
Mouse Model
25%
Malignant Neoplasm
23%
Immunotherapy
18%
Ischemic Heart Disease
18%
Voltage Gated Sodium Channel
17%
Efficacy Assessment
17%
Safety Assessment
17%
Tumor Necrosis Factor Receptor Associated Factor 6
17%
Doxorubicin
17%
Iodine-125
17%
Heart Infarction
16%
Liposome
15%
Leporidae
15%
Cardiovascular Disease
14%
Pharmacokinetics
12%
Nitric Oxide Synthase
12%
Copper 64
11%
Apolipoprotein E
10%
Combination Therapy
10%
Nanoemulsion
10%
Solid Lipid Nanoparticle
9%
Glucose Polymer
9%
Sepsis
9%
Receptor
9%
Fluorine 18
9%
Disease Exacerbation
9%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
8%
Piglet
8%
Rapamycin
8%
Drug Carrier
8%
Integrin
8%
Thrombosis
8%
Experimental Atherosclerosis
8%
Colony Stimulating Factor 1
8%
Staphylococcus Aureus
8%
Prosaposin
8%
Epitope
8%
Drug Development
8%
Medicine and Dentistry
Positron Emission Tomography
62%
Atherosclerosis
52%
Nanoparticle
47%
Macrophage
47%
Zirconium 89
25%
Nanomedicine
23%
Positron Emission Tomography - Magnetic Resonance Imaging
22%
Myeloid Cell
20%
Neoplasm
18%
Malignant Neoplasm
17%
Ischemic Heart Disease
17%
Myocardial Infarction
13%
Disease
12%
Cardiovascular Disease
12%
Fluorine-18
11%
Personalized Medicine
11%
Cardiovascular Imaging
11%
Liposome
10%
High-Density Lipoprotein
10%
Glucose Polymer
9%
Sepsis
9%
Ex Vivo
8%
Safety Assessment
8%
Urinary Excretion
8%
Doxorubicin
8%
Prosaposin
8%
Copper 64
8%
Interleukin 4
8%
Phagocyte
8%
Molecular Imaging
8%
Efficacy Assessment
8%
Contrast Medium
8%
Photoacoustic Tomography
8%
Epitope
8%
Integrin
8%
Tumor Necrosis Factor Receptor Associated Factor 6
8%
Malonaldehyde
8%
Nuclear Imaging
8%
Restylane
8%
Thrombosis
8%
Biodistribution
8%
Magnetic Resonance Imaging
8%
Apolipoprotein E
7%
Immunocompetent Cell
7%
Positron Emission Tomography-Computed Tomography
6%
Mechanistic Target of Rapamycin
6%
Phenotype
5%
Hematological System
5%
Fluorodeoxyglucose F 18
5%
Imaging Technique
5%
